Publication Date:
2014-03-28
Description:
SKLB-163, a new benzothiazole-2-thiol derivative, exhibits potent anticancer activity by affecting RhoGDI/JNK-1 signaling pathway Cell Death and Disease 5, e1143 (March 2014). doi:10.1038/cddis.2014.107 Authors: X Peng, G Xie, Z Wang, H Lin, T Zhou, P Xiang, Y Jiang, S Yang, Y Wei, L Yu & Y Zhao
Keywords:
benzothiazole-2-thiol derivativecancerRhoGDIapoptosisproliferation
Electronic ISSN:
2041-4889
Topics:
Biology
,
Medicine
Permalink